THE FIRST CASE OF STEPHANOASCUS CIFERRII INFECTION IN A NEWBORN AND REVIEW OF LITERATURE

Abstract

Intensive care unit patients have the risk for fungal infections, especially when broad-spectrum antibiotics and long-term indwelling catheters are used. We are here reporting a very rare fungus, Stephanoascus ciferrii, which caused cutaneous and systemic infections in a neonate, followed in Neonatal Intensive Care Unit. In contrast with other few cases of S. ciferrii, the fungus presented here, was detected as more susceptible to antifungal agents such as amphotericin B, flucytosine, fluconazole, and voriconazole. Emerge of rare and unusual fungal agents should always be considered in high-risk patients with use of broad-spectrum antibiotics.